Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020;27(4):347-349.
doi: 10.5603/CJ.a2020.0067. Epub 2020 May 18.

Direct oral anticoagulants in cancer-associated venous thromboembolism: It is high time for a change of therapeutic paradigm

Justyna Domienik-Karłowicz  1 , Miłosz Jaguszewski  2 , Marcin Kurzyna  3
Affiliations
Comment

Direct oral anticoagulants in cancer-associated venous thromboembolism: It is high time for a change of therapeutic paradigm

Justyna Domienik-Karłowicz et al. Cardiol J. 2020.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared

Comment on

  • Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer.
    Agnelli G, Becattini C, Meyer G, Muñoz A, Huisman MV, Connors JM, Cohen A, Bauersachs R, Brenner B, Torbicki A, Sueiro MR, Lambert C, Gussoni G, Campanini M, Fontanella A, Vescovo G, Verso M; Caravaggio Investigators. Agnelli G, et al. N Engl J Med. 2020 Apr 23;382(17):1599-1607. doi: 10.1056/NEJMoa1915103. Epub 2020 Mar 29. N Engl J Med. 2020. PMID: 32223112 Clinical Trial.

References

    1. Agnelli G, Becattini C, Meyer G, et al. Caravaggio Investigators. Apixaban for the treatment of venous thromboembolism associated with cancer. N Engl J Med. 2020;382(17):1599–1607. doi: 10.1056/NEJMoa1915103. - DOI - PubMed
    1. Kuderer NM, Ortel TL, Francis CW. Impact of venous thromboembolism and anticoagulation on cancer and cancer survival. J Clin Oncol. 2009;27(29):4902–4911. doi: 10.1200/JCO.2009.22.4584. - DOI - PMC - PubMed
    1. Chew HK, Wun T, Harvey D, et al. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med. 2006;166(4):458–464. doi: 10.1001/archinte.166.4.458. - DOI - PubMed
    1. Horsted F, West J, Grainge MJ. Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis. PLoS Med. 2012;9(7):e1001275. doi: 10.1371/journal.pmed.1001275. - DOI - PMC - PubMed
    1. Lee AYY, Levine MN, Baker RI, et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med. 2003;349(2):146–153. doi: 10.1056/NEJMoa025313. - DOI - PubMed